Pulmonary Pharmacology 1996-01-01

Effect of Isoenzyme Selective Phosphodiesterase Inhibitors on the Proliferation of Murine Thymus and Spleen Cells

K.H. Banner, B. Bertin, I. Moodley, C.P. Page

Index: Pulm. Pharmacol. 9(1) , 35-41, (1996)

Full Text: HTML

Abstract

The effects of isoenzyme selective phosphodiesterase inhibitors on mitogen-stimulated proliferation of murine thymus and spleen cells was determined. The type 4 phosphodiesterase inhibitors, (rolipram, RO 20-1724 and denbufylline) and the mixed type 3/4 inhibitors, (zardaverine and benzafentrine) produced a concentration-related inhibition of mitogen stimulated thymus and spleen cell proliferation. Combined addition of the type 4 inhibitor, rolipram and the type 3 inhibitor, SK&F 94836 had no antiproliferative effect additional to that of rolipram alone. The thymus cells were more sensitive to the type 4 inhibitors than the spleen cells. The type 3 phosphodiesterase inhibitor, SK&F 94836 significantly inhibited cell proliferation, but only at high concentrations. The type 1 (vinpocetine) and the type 5 (zaprinast) phosphodiesterase inhibitor had no significant effect on proliferation. These results suggest that thymus and to a lesser extent spleen cell proliferation is dependent on the activity of the type 4 phosphodiesterase isoenzyme.


Related Compounds

  • Zardaverine

Related Articles:

Uncovering caffeine's adenosine A2A receptor inverse agonism in experimental parkinsonism.

2014-11-21

[ACS Chem. Biol. 9(11) , 2496-501, (2014)]

Dopamine receptors D3 and D5 regulate CD4(+)T-cell activation and differentiation by modulating ERK activation and cAMP production.

2015-07-15

[J. Neuroimmunol. 284 , 18-29, (2015)]

Phenotype-based screening of mechanistically annotated compounds in combination with gene expression and pathway analysis identifies candidate drug targets in a human squamous carcinoma cell model.

2006-08-01

[J. Biomol. Screen. 11(5) , 457-68, (2006)]

The specific type III and IV phosphodiesterase inhibitor zardaverine suppresses formation of tumor necrosis factor by macrophages.

1993-01-05

[Eur. J. Pharmacol. 230(1) , 9-14, (1993)]

Crystal structure of phosphodiesterase 4D and inhibitor complex(1).

2002-10-23

[FEBS Lett. 530(1-3) , 53-8, (2002)]

More Articles...